Publications by authors named "Sandra Sim"

Claim this Profile
C
Correction to "Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 M Inhibitor with Pan-Coronavirus Activity".
Qian Wen Tan, Subramanyam Vankadara, Jia Yi Fong, Yi Yang See, Nithya Baburajendran, Sandra Sim

J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 M Inhibitor with Pan-Coronavirus Activity.
Qian Wen Tan, Subramanyam Vankadara, Jia Yi Fong, Yi Yang See, Nithya Baburajendran, Sandra Sim

J Med Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria.
Benjamin R Taft, Fumiaki Yokokawa, Tom Kirrane, Anne-Catherine Mata, Richard Huang, Oliver Simon, Sandra Sim, Simon Campbell

J Med Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors.
Pearly Shuyi Ng, Klement Foo, Sandra Sim, Gang Wang, Chuhui Huang

Bioorg Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis